Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells
- PMID: 17371955
- DOI: 10.4049/jimmunol.178.7.4022
Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells
Abstract
TGF-beta is a pluripotent cytokine that is capable of inducing the expression of Foxp3 in naive T lymphocytes. TGF-beta-induced cells are phenotypically similar to thymic-derived regulatory T cells in that they are anergic and suppressive. We have examined the cytokine and costimulatory molecule requirements for TGF-beta-mediated induction and maintenance of Foxp3 by CD4(+)Foxp3(-) cells. IL-2 plays a non-redundant role in TGF-beta-induced Foxp3 expression. Other common gamma-chain-utilizing cytokines were unable to induce Foxp3 expression in IL-2-deficient T cells. The role of CD28 in the induction of Foxp3 was solely related to its capacity to enhance the endogenous production of IL-2. Foxp3 expression was stable in vitro and in vivo in the absence of IL-2. As TGF-beta-induced T regulatory cells can be easily grown in vitro, they may prove useful for the treatment of autoimmune diseases, for the prevention of graft rejection, and graft versus host disease.
Similar articles
-
Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.J Immunol. 2007 Jan 1;178(1):179-85. doi: 10.4049/jimmunol.178.1.179. J Immunol. 2007. PMID: 17182553
-
Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity.J Immunol. 2007 Jan 1;178(1):172-8. doi: 10.4049/jimmunol.178.1.172. J Immunol. 2007. PMID: 17182552
-
Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.PLoS One. 2010 Dec 17;5(12):e15150. doi: 10.1371/journal.pone.0015150. PLoS One. 2010. PMID: 21179414 Free PMC article.
-
Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.Trends Immunol. 2008 Sep;29(9):429-35. doi: 10.1016/j.it.2008.06.005. Epub 2008 Aug 3. Trends Immunol. 2008. PMID: 18676178 Review.
-
FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13. Transpl Immunol. 2012. PMID: 21939765 Review.
Cited by
-
Modeling the effect of environmental cytokines, nutrient conditions and hypoxia on CD4+ T cell differentiation.Front Immunol. 2022 Sep 23;13:962175. doi: 10.3389/fimmu.2022.962175. eCollection 2022. Front Immunol. 2022. PMID: 36211418 Free PMC article.
-
FIST, a sword and shield fusokine for cancer immunotherapy.Oncoimmunology. 2012 Mar 1;1(2):224-226. doi: 10.4161/onci.1.2.18458. Oncoimmunology. 2012. PMID: 22720250 Free PMC article.
-
mTOR inhibitors effects on regulatory T cells and on dendritic cells.J Transl Med. 2016 May 31;14(1):152. doi: 10.1186/s12967-016-0916-7. J Transl Med. 2016. PMID: 27245075 Free PMC article. Review.
-
T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis.Mucosal Immunol. 2015 Nov;8(6):1297-312. doi: 10.1038/mi.2015.20. Epub 2015 Mar 25. Mucosal Immunol. 2015. PMID: 25807185 Free PMC article.
-
Osteoclast activated FoxP3+ CD8+ T-cells suppress bone resorption in vitro.PLoS One. 2012;7(6):e38199. doi: 10.1371/journal.pone.0038199. Epub 2012 Jun 6. PLoS One. 2012. PMID: 22701612 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials